These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 19911371)
21. Imaging the localized protein interactions between Pit-1 and the CCAAT/enhancer binding protein alpha in the living pituitary cell nucleus. Day RN; Voss TC; Enwright JF; Booker CF; Periasamy A; Schaufele F Mol Endocrinol; 2003 Mar; 17(3):333-45. PubMed ID: 12554785 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1). Sánchez-Álvarez M; Montes M; Sánchez-Hernández N; Hernández-Munain C; Suñé C J Biol Chem; 2010 May; 285(20):15220-15233. PubMed ID: 20215116 [TBL] [Abstract][Full Text] [Related]
23. The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing. Sánchez-Hernández N; Boireau S; Schmidt U; Muñoz-Cobo JP; Hernández-Munain C; Bertrand E; Suñé C RNA; 2016 Apr; 22(4):571-82. PubMed ID: 26873599 [TBL] [Abstract][Full Text] [Related]
24. Protein-x of hepatitis B virus in interaction with CCAAT/enhancer-binding protein α (C/EBPα)--an in silico analysis approach. Mohamadkhani A; Shahnazari P; Minuchehr Z; Madadkar-Sobhani A; Tehrani MJ; Jazii FR; Poustchi H Theor Biol Med Model; 2011 Oct; 8():41. PubMed ID: 22035036 [TBL] [Abstract][Full Text] [Related]
25. PKCδ enhances C/EBPα degradation via inducing its phosphorylation and cytoplasmic translocation. Wu ZX; Zhao M; Xia L; Yu Y; Shen SM; Han SF; Li H; Wang TD; Chen GQ; Wang LS Biochem Biophys Res Commun; 2013 Apr; 433(2):220-5. PubMed ID: 23473759 [TBL] [Abstract][Full Text] [Related]
26. Dynamic interactions between Pit-1 and C/EBPalpha in the pituitary cell nucleus. Demarco IA; Voss TC; Booker CF; Day RN Mol Cell Biol; 2006 Nov; 26(21):8087-98. PubMed ID: 16908544 [TBL] [Abstract][Full Text] [Related]
27. Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing. Pearson JL; Robinson TJ; Muñoz MJ; Kornblihtt AR; Garcia-Blanco MA J Biol Chem; 2008 Mar; 283(12):7949-61. PubMed ID: 18187414 [TBL] [Abstract][Full Text] [Related]
28. Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines. Wang GL; Shi X; Salisbury E; Timchenko NA Exp Cell Res; 2008 Apr; 314(7):1626-39. PubMed ID: 18313667 [TBL] [Abstract][Full Text] [Related]
29. Conformation of CCAAT/enhancer-binding protein alpha dimers varies with intranuclear location in living cells. Schaufele F; Wang X; Liu X; Day RN J Biol Chem; 2003 Mar; 278(12):10578-87. PubMed ID: 12531886 [TBL] [Abstract][Full Text] [Related]
30. Transcriptional Elongation Regulator 1 Affects Transcription and Splicing of Genes Associated with Cellular Morphology and Cytoskeleton Dynamics and Is Required for Neurite Outgrowth in Neuroblastoma Cells and Primary Neuronal Cultures. Muñoz-Cobo JP; Sánchez-Hernández N; Gutiérrez S; El Yousfi Y; Montes M; Gallego C; Hernández-Munain C; Suñé C Mol Neurobiol; 2017 Dec; 54(10):7808-7823. PubMed ID: 27844289 [TBL] [Abstract][Full Text] [Related]
31. The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles. Sánchez-Hernández N; Ruiz L; Sánchez-Álvarez M; Montes M; Macias MJ; Hernández-Munain C; Suñé C J Biol Chem; 2012 May; 287(21):17789-17800. PubMed ID: 22453921 [TBL] [Abstract][Full Text] [Related]
32. Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA. Yoon S; Rossi JJ Adv Exp Med Biol; 2017; 983():173-188. PubMed ID: 28639199 [TBL] [Abstract][Full Text] [Related]
34. Commitment Complex Splicing Factors in Cancers of the Gastrointestinal Tract-An In Silico Study. Zhang Y; Simko AC; Okoro U; Sibert DJ; Moon JH; Liu B; Matin A Bioinform Biol Insights; 2024; 18():11779322241287115. PubMed ID: 39421280 [TBL] [Abstract][Full Text] [Related]
35. Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma. Kim K; Shin HJ; Park SC; Kim Y; Lee MH; Moon JH; Kim EH; Lee EJ; Kang CW; Ku CR J Endocrinol Invest; 2024 Oct; ():. PubMed ID: 39361240 [TBL] [Abstract][Full Text] [Related]
36. Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells. Demirci S; Doğan A; Apdik H; Tuysuz EC; Gulluoglu S; Bayrak OF; Şahin F Mol Cell Biochem; 2018 Jan; 437(1-2):133-142. PubMed ID: 28620820 [TBL] [Abstract][Full Text] [Related]
37. Nuclear redistribution of TCERG1 is required for its ability to inhibit the transcriptional and anti-proliferative activities of C/EBPalpha. Banman SL; McFie PJ; Wilson HL; Roesler WJ J Cell Biochem; 2010 Jan; 109(1):140-51. PubMed ID: 19911371 [TBL] [Abstract][Full Text] [Related]
38. TCERG1 inhibits C/EBPα through a mechanism that does not involve sequestration of C/EBPα at pericentromeric heterochromatin. Moazed B; Banman SL; Wilkinson GA; Roesler WJ J Cell Biochem; 2011 Sep; 112(9):2317-26. PubMed ID: 21503969 [TBL] [Abstract][Full Text] [Related]
39. The Glutamine-Alanine Repeat Domain of TCERG1 is Required for the Inhibition of the Growth Arrest Activity of C/EBPα. Miller NJ; Schick K; Timchenko N; Harrison E; Roesler WJ J Cell Biochem; 2016 Mar; 117(3):612-20. PubMed ID: 26264132 [TBL] [Abstract][Full Text] [Related]
40. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]